InspireMD (NSPR) EBT Margin Growth (3y) (2013 - 2025)
InspireMD (NSPR) EBT Margin Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -222.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -480.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,114.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1,391.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -176.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 329.00 |
| 10 | InspireMD | 45.74 Mn | -8.48 Mn | 1.18 Mn | 133,637.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 133,637.00 |
| Sep 30, 2025 | -20,079.00 |
| Jun 30, 2025 | -42,942.00 |
| Mar 31, 2025 | -37,073.00 |
| Dec 31, 2024 | 118,777.00 |
| Sep 30, 2024 | -8,740.00 |
| Jun 30, 2024 | -13,712.00 |
| Mar 31, 2024 | -16,830.00 |
| Dec 31, 2023 | 202,335.00 |
| Sep 30, 2023 | -13,842.00 |
| Jun 30, 2023 | 47,002.00 |
| Mar 31, 2023 | -15,814.00 |
| Dec 31, 2022 | -21,944.00 |
| Sep 30, 2022 | -9,604.00 |
| Jun 30, 2022 | -13,988.00 |
| Mar 31, 2022 | 39,399.00 |
| Dec 31, 2021 | -2,440.00 |
| Sep 30, 2021 | -11,860.00 |
| Jun 30, 2021 | -27,535.00 |
| Mar 31, 2021 | -8,513.00 |